Terence R. Lichtor, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2800 Westhill Dr, Ste 200, Wausau, WI 54401 Phone: 715-843-1000 Fax: 715-843-1001 |
Jamie R Lyons, PA-C Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 Westhill Dr Ste 201, Wausau, WI 54401 Phone: 715-847-2382 Fax: 715-847-2381 |
Craig R Kelman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 425 Pine Ridge Blvd Ste 300, Wausau, WI 54401 Phone: 715-847-2000 |
Dr. Christopher I. Mackay, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 505 S 24th Ave Ste 200, Wausau, WI 54401 Phone: 715-396-3191 Fax: 715-396-3191 |
Brian Edward Bunch, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3200 Westhill Dr, Suite 102, Wausau, WI 54401 Phone: 715-847-2019 Fax: 715-847-2668 |
Dr. Andrew Beaumont, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 425 Pine Ridge Blvd, Suite 300, Wausau, WI 54401 Phone: 715-847-2019 |
News Archive
"An effective vaccine against the AIDS virus may have moved one step closer to reality, researchers said Thursday," the Los Angeles Times reports. "Federal researchers have identified a pair of naturally occurring antibodies that are able to kill more than 90% of all strains of the AIDS virus, a finding they say could lead to the development of new treatments for HIV infections and to the production of the first successful vaccine against the virus" (Maugh, 7/9).
Today the Child Neurology Foundation, named Elizabeth A. Thiele, MD, PhD, as its 2014 Infantile Spasms (IS) Heroes Award winner to help kick off IS Awareness Week (December 5-11, 2014). The IS Heroes Award was established in 2010 by CNF, www.childneurologyfoundation.org, to recognize a deserving healthcare professional for making a positive difference in the life of a child with infantile spasms.
Premature newborns are 32% less likely to die if they are admitted to high volume neonatal units rather than low volume, according to new research.
GTC Biotherapeutics, Inc. announced the closing of a new $7 million secured convertible debt financing by its strategic partner, LFB Biotechnologies SAS, in connection with a restructuring of GTC's operations which will result in a downsizing of approximately 30 full-time positions at its headquarters and an additional 20 positions at its farm facility.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
› Verified 1 days ago